|
|
||||||||
Federative Research Institute 66, Bordeaux, France
Key Words. Lentiviral vector • Gene transfer • CD34+ • CD34+/38-/lin- • Mobilized peripheral blood • Prestimulation
Hubert de Verneuil, MD., PhD., INSERM E0217, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076-Bordeaux Cedex, France. Telephone: 33-5-57-57-13-70; Fax: 33-5-56-98-33-48; e-mail: verneuil{at}pmtg.u-bordeaux2.fr
Because mobilized peripheral blood (mPB) represents an attractive source of cells for gene therapy, we investigated lentiviral gene transfer in CD34+ cells and the stem/progenitor-cell-enriched CD34+/38-/lin- cell subset isolated from mPB. In this study, we used an optimized third-generation self-inactivating lentiviral vector containing both the central polypurine tract and the woodchuck hepatitis posttranscriptional regulatory element sequences and encoding enhanced green fluorescent protein (EGFP) under the control of the elongation factor l
promoter. This lentivector was first used to compare multiplicity of infection (MOI)-dependent gene transfer efficiency in cord blood (CB) versus mPB CD34+-derived cells, colony-forming cells (CFCs), and long-term culture-initiating cells (LTC-ICs). Results showed a difference in the percentage of transduced cells particularly significant at low MOIs. A plateau was reached where 15% and 25% of CB and mPB cells, respectively, remained refractory to lentiviral trans-duction. Effects of a cytokine prestimulation period (18 hours) with interleukin-3, stem cell factor, Flt-3 ligand, and thrombopoietin were then analyzed in total cells, CFCs, and LTC-ICs derived from mPB CD34+ cells. Transduction levels in those conditions demonstrated a two- and fourfold increase in CFCs and LTC-ICs, respectively, compared with unstimulated (<3 hours) control cells. Moreover, using the same transduction protocol, we were able to efficiently transduce CD34+/38-/lin- cells isolated from mPB, with up to >85% of colonies derived from LTC-ICs expressing EGFP and gene transfer levels remaining stable for 10 weeks in liquid culture. We therefore demonstrate a highly efficient gene transfer in this therapeutically relevant target cell population.
This article has been cited by other articles:
![]() |
M. Tesio, L. Gammaitoni, M. Gunetti, V. Leuci, Y. Pignochino, N. Jordaney, S. Capellero, C. Cammarata, L. Caione, G. Migliaretti, et al. Sustained Long-Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors Stem Cells, June 1, 2008; 26(6): 1620 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Rezvani, F. Mazurier, M. Cario-Andre, C. Pain, C. Ged, A. Taieb, and H. de Verneuil Protective Effects of Catalase Overexpression on UVB-induced Apoptosis in Normal Human Keratinocytes J. Biol. Chem., June 30, 2006; 281(26): 17999 - 18007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
